The US DNA Vaccine market is anticipated to grow at a CAGR 42.9% during the forecast period. The factors affecting the growth of DNA vaccination in the US include R&D funding, high healthcare expenditure, presence of key players and rising prevalence of cancer patients. A significant rise in R&D funding has witnessed in the past few years. For example, In April 2018, Inovio Pharmaceuticals Inc., a US firm has awarded approximately $56 million from CEPI (the Coalition for Epidemic Preparedness Innovations) for the development of DNA vaccines against MERS (Middle East Respiratory Syndrome) and Lassa fever. In addition, increasing poultry production in the country is also a major contributing factor for DNA vaccination in the US. According to the Poultry world, In the US, poultry production is set to an all-time high. It is expected to rise 3% annually from 2019 to 2021.
Get Free Sample link @ https://www.omrglobal.com/request-sample/us-dna-vaccines-market
The US DNA vaccine is further segmented into type, technology, and application. Based on type, the market is segmented into animal DNA vaccine and human DNA vaccine. Based on technology, the market is segmented into plasmid DNA vaccine and plasmid DNA delivery. Based on application, the market is segmented into oncology, infectious disease and others. The US poultry farms such as Tyson Foods and Costo Poultry farm are planning to raise chicken production. Since 1993, Sanderson Farms has added seven plants. Costco’s $300 million plants in Nebraska are expected to produce nearly 100 million chickens in a year, while open in April 2019.
A full report of US DNA Vaccine Market available @ https://www.omrglobal.com/industry-reports/us-dna-vaccines-market
- Market Coverage
- Market number available for – 2019-2025
- Base year- 2019
- Forecast period- 2020-2025
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
US DNA Vaccine Market by Type
- Animal DNA Vaccine
- Human DNA Vaccine
US DNA Vaccine Market by Technology
- Plasmid DNA Vaccine
- Plasmid DNA Delivery
US DNA Vaccine Market by Application
- Oncology
- Infectious Disease
- Others
Company Profiles
- Arbutus Biopharma Corp.
- Dendreon Pharmaceuticals LLC
- GE Healthcare
- Glaxosmithkline PLC.
- Green Cross Corp.
- Immunomic Therapeutics
- Innovio Biomedical Corp.
- Merck & Co.
- Pfizer Inc.
- Protein Sciences Corp.
- Qed Biosciences Inc.
- Sanofi Inc.
- Tolerion Inc.
- Vical Inc.
- Zoetis Inc.
The Report Covers
- Comprehensive research methodology of the US DNA Vaccine market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the US DNA Vaccine market.
- Insights about market determinants which are stimulating the US DNA Vaccine market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-dna-vaccines-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
